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Abstract
Background: Tinnitus is a frequent, debilitating hearing disorder associated with severe emotional and
psychological suffering. Although a link between stress and tinnitus has been widely recognized, the empirical
evidence is scant. Our aims were to test for dysregulation of the stress-related hypothalamus-pituitary adrenal
(HPA) axis in tinnitus and to examine ear sensitivity variations with cortisol manipulation.
Methods: Twenty-one tinnitus participants and 21 controls comparable in age, education, and overall health status
but without tinnitus underwent basal cortisol assessments on three non-consecutive days and took 0.5 mg of
dexamethasone (DEX) at 23:00 on the first day. Cortisol levels were measured hourly the next morning. Detection
and discomfort hearing thresholds were measured before and after dexamethasone suppression test.
Results: Both groups displayed similar basal cortisol levels, but tinnitus participants showed stronger and longer-
lasting cortisol suppression after DEX administration. Suppression was unrelated to hearing loss. Discomfort
threshold was lower after cortisol suppression in tinnitus ears.
Conclusions: Our findings suggest heightened glucocorticoid sensitivity in tinnitus in terms of an abnormally
strong glucocorticoid receptor (GR)-mediated HPA-axis feedback (despite a normal mineralocorticoid receptor (MR)-
mediated tone) and lower tolerance for sound loudness with suppressed cortisol levels. Long-term stress exposure
and its deleterious effects therefore constitute an important predisposing factor for, or a significant pathological
consequence of, this debilitating hearing disorder.
Keywords: Cortisol, Hearing sensitivity, Hearing threshold, HPA axis, Low-dose dexamethasone suppression test,
Stress, Tinnitus
Background
Subjective tinnitus ("tinnitus”) is the perception of sound
in the ears or head in the absence of an external sound
and difficult to treat. Individuals with tinnitus can
experience severe emotional distress, depression, anxiety,
and insomnia [1-5]. A recent study in 14,278 adults
reported an overall prevalence of 25.3% for any experi-
ence of tinnitus in the previous year and 7.9% for fre-
quent or constant (at least once a day) tinnitus [6].
Prevalence increases with age, peaking at 31.4% and
14.3% from age 60 to 69 years for these two tinnitus fre-
quencies, respectively [6]. The increasing prevalence
with age is not surprising, because hearing loss is
known to be an associated risk factor for tinnitus [7].
With increasing life expectancy, and because hearing
loss and noise exposure are increasingly affecting mili-
tary personnel [8,9] and youth [10], tinnitus has become
a significant public health issue.
Hearing loss predicts tinnitus presence, but not sever-
ity [11,12]. Conversely, individuals with hearing loss do
not necessarily experience tinnitus. There is therefore a
need to determine other factors for this debilitating
hearing disorder and its consequences for health in
order to better prevent and treat it. One likely candidate
is stress. Because stress has long been identified as a
t r i g g e ro rc o - m o r b i d i t yo ft i n n i t u s ,b a s e dm a i n l yo n
anecdotal and retrospective reports, this idea has been
taken for granted in classical teachings on tinnitus [13].
In addition, recent large population studies have estab-
lished that emotional exhaustion and long-term stress
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[14,15]. Functional and electroencephalographic brain
imaging studies have also shown aberrant links between
limbic (involved in emotions) and auditory system struc-
tures [16-18]. Structural brain differences (i.e., grey mat-
ter decrease) in tinnitus involving parts of the limbic
system have also been reported. More specifically, less
grey matter in the nucleus accumbens [18,19] and the
left hippocampus [20] suggests a depletion that could be
related to long-term exposure to stress, among other
factors.
Another line of research has focused on the hypotha-
lamus-pituitary-adrenal (HPA) axis functioning responsi-
ble for the stress response via the stress hormone
cortisol. In a first study, overall or chronic basal cortisol
levels (secreted naturally in a circadian pattern) were
higher in a subsample of tinnitus participants when
levels were considered over a one-week period, although
diurnal levels were similar to those of age-matched con-
trols [21,22]. In a further study [23], tinnitus participants
were submitted to the Trier Social Stress Test [24].
They showed delayed and blunted cortisol response to
the stressor despite similar psychological stress levels to
age-matched controls. This response is similar to that of
patients with chronic fatigue syndrome [25], suggesting
an exhausted stress response due to long-term stress in
tinnitus participants. The apparent contradiction
between these two studies could be explained by the
fact that basal cortisol levels and stress responsiveness
are modulated by two distinct feedback systems. Circu-
lating glucocorticoids are released by the HPA axis and
bind with two kinds of receptors: the high-affinity
mineralocorticoid receptor (MR) and the lower-affinity
glucocorticoid receptor (GR). The HPA axis is a closed-
loop system that is subjected to a tight negative feed-
back control mediated by these two receptor types. HPA
axis tone, assessed in basal cortisol levels, is regulated
by the MR receptors [26]. Stress responsiveness is deter-
mined by the GR receptors, which are more critical for
terminating the HPA axis stress response, and are
located in many brain areas such as the hypothalamus,
brain stem, hippocampus, amygdala, and pituitary gland,
as well as the inner ear.
A noninvasive way to test for exhausted HPA axis
hypothesis in tinnitus participants is to examine the sen-
sitivity of the HPA axis negative feedback response to
glucocorticoids. The Dexamethasone (DEX) suppression
test is a pharmacological challenge that is widely used
to test for HPA axis dysregulation in clinical populations
such as patients with depression or post-traumatic stress
disorder. Dexamethasone is a synthetic glucocorticoid
with high GR receptor affinity that does not cross the
blood-brain barrier [27-29]. Because the pituitary gland
is located outside the blood-brain barrier, DEX
selectively activates the pituitary GR, leaving the pitui-
tary MR and the MR and GR in other brain tissues
unaffected [30,31]. Once the pituitary GRs are activated,
they downregulate cortisol production further down the
HPA axis in the adrenal cortex. The DEX suppression
test is therefore a direct test for an altered effect of GR
activation in the pituitary on cortisol secretion [32], and
it indicates the sensitivity of the HPA axis negative feed-
back response to glucocorticoids. Depressed patients
often show HPA axis hyperactivity and nonsuppression
of HPA axis cortisol secretion after DEX administration
[33]. In contrast, patients suffering from post-traumatic
stress disorder often display cortisol hypersuppression.
Hypersuppression is detected by using a lower dose of
DEX (0.5 mg instead of 1 mg) to better discriminate
HPA axis feedback sensitivity between patients and con-
trols [34].
In the present study, both basal cortisol and HPA axis
response to the low-dose DEX test were measured in
tinnitus participants and controls comparable in age,
education, and overall health status. By assessing MR-
mediated (basal) as well as GR-mediated (cortisol sup-
pression after DEX administration) feedback in the same
participants, both feedback systems were assessed simul-
taneously to gain a more global insight into HPA axis
anomalies in tinnitus participants. If tinnitus participants
display greater sensitivity to HPA axis negative feedback
(GR-mediated), they should display hypersuppression
after DEX administration compared to age-matched
controls, despite normal basal (MR-mediated) cortisol
levels.
In addition, hearing thresholds were assessed before
and after pharmacological challenge to examine the
effects of cortisol manipulation on both detection and
discomfort thresholds. Glucocorticoid receptors (GR)
have been found in abundance in the human inner ear
[35], but their function remains unclear. Although no
studies have examined the effects of experimental
manipulation of cortisol suppression on hearing detec-
tion thresholds in humans, there is some evidence that
cortisol increase exerts a direct influence on hearing.
For instance, patients with adrenal cortical insufficiency
(a quasi-total absence of cortisol secretion, such as in
Addison’s disease) had more acute auditory detection
sensitivity and lower discomfort threshold than matched
controls [36]. When corticosteroid levels were restored
to normal via administration of exogenous glucocorti-
coids, auditory measures reverted to normal. This effect
has been replicated in rats [37]. Experimentally
increased cortisol concentrations in normal adults have
resulted in reduced auditory sensitivity at high frequen-
cies [38]. The opposite effect was recently reported in
rats, however, although the cortisol increase was
induced by a stressful stimulus and not cortisol
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lent showed higher cortisol levels but lower hearing
thresholds [39]. To our knowledge, the effects of cortisol
manipulation on hearing discomfort thresholds have
never been assessed in human participants with tinnitus.
Yet, it is estimated that increased hearing sensitivity is
present in 80% of patients with tinnitus [40]. Discomfort
thresholds have also been found to predict tinnitus pre-
valence and severity in the general population [12].
Based on human studies, it was thus hypothesized that
detection and discomfort thresholds in both tinnitus
and control participants would be lower after cortisol
suppression, and possibly to a greater extent in tinnitus
than in control ears due to their greater sensitivity to
cortisol manipulation.
Methods
Participants
Twenty-one participants (11 men and 10 women) with
chronic tinnitus for at least six months (mean duration
of tinnitus was 16.6 years, SD = 15.7) and 21 controls
without tinnitus (10 men and 11 women) were recruited
through newspaper advertisements, word of mouth, and
a self-help local tinnitus association. Thirteen tinnitus
participants had bilateral (perceived in both ears or the
head) and eight had unilateral (perceived in one ear
only) tinnitus. Groups were similar in age, educational
level, and body mass index (see Table 1). All partici-
pants were in good physical and mental health. Strin-
gent exclusion criteria were used: taking medication that
interferes with the HPA axis (e.g., beta-blockers, anti-
depressants), having a disease that interferes with the
HPA axis (e.g., diabetes, uncontrolled hypo-or hyperten-
sion, lupus), having jet lag or having undergone surgery
in the past six months, smoking, wearing a hearing aid,
and having a BMI of 30 or more. All women were post-
menopausal, and two (one in each group) were taking
hormone replacement therapy.
Questionnaires
All participants were tested for symptoms of depression
using the Beck Depression Inventory II [41], with similar
scores for the two groups (see Table 1). Subjective tinni-
tus severity was assessed in tinnitus participants with
the French version of the Tinnitus Reaction Question-
naire [42].
Cortisol assessment and manipulation
To assess basal cortisol levels, five saliva samples per
day were collected at home for three days on Day 1, 3,
and 5 at awakening, 30 minutes after awakening, before
lunch, before dinner, and before going to bed. One day
of rest (Day 4) was provided between basal cortisol sam-
pling days.
To assess HPA axis reactivity to DEX, all participants
took 0.5 mg of DEX at home at 23:00 on Day 1. Saliva
samples were taken in the lab at 8:00, 9:00, 10:00, 11:00,
and 12:00 the following day (Day 2). Post-DEX cortisol
assessment was always performed between Day 1 and
Day 3 so that post-DEX days were consistently timed
across participants. Figure 1 presents a schematic dia-
gram of the procedure.
Participants took saliva samples at home for Day 1, 3,
and 5 using a Salivette (Sarstedt Inc., Nümbrecht, Ger-
many) and stored them in the refrigerator. When
returned to the lab, all samples were stored at -20°C.
S a l i v as a m p l e st a k e ni nt h el a b( D a y2 )w e r es t o r e dt h e
same day at -20°C. All samples were recoded for blind
analysis before being sent to Trier University (Germany),
where cortisol levels were determined with a time-
resolved fluorescence immunoassay. The inter-assay
coefficient of variation was < 50%.
Hearing assessment
Hearing detection and discomfort thresholds were mea-
sured on Days 0 and 2 at the same time of day in a
soundproof booth at the laboratory, meaning for
instance that if participants came at 10:00 on Day 0,
hearing detection and discomfort thresholds were
assessed at 10:00 also on Day 2. Detection thresholds
were assessed for half-octave frequency steps from 250
to 8,000 Hz using an adaptive psychophysical automated
p r o c e d u r e( - 5 ,+ 3 ,- 1 ,+ 1 ) .T h et h r e s h o l dw a sd e t e r -
mined as the mean of the last 8 reversals. Hearing dis-
comfort thresholds were assessed for frequencies 1 kHz,
2 kHz, and 4 kHz using the methods of limits in 5 dB
intensity steps. Threshold was determined as the level at
which the sound was judged too loud [43]. Trains of
Table 1 Sociodemographic and questionnaire data on the Tinnitus and Control groups
Tinnitus (N = 21) Controls (N = 21) P value
Age (SD) 65.7 (7.1) 65.7 (8.7) 1.0
Education (SD) 14.2 (2.8) 15.3 (3.3) .48
Body Mass Index (SD) 24.1 (2.6) 23.4 (3.6) .23
Beck Depression Inventory (SD) 5.2 (5.2) 4.2 (4.2) .52
Tinnitus Reaction Questionnaire (SD) 11.5 (9.97) ––
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silence (20 ms rise and fall), were used in both tasks.
The entire procedure was automated and programmed
with Matlab using a real-time signal processing system
(Tucker Davis Technology-3) under Sennheiser HD265
headphones calibrated with a Larson-Davis sound level
meter combined with an artificial ear AEC101 and a
2559 model microphone.
The experiment was approved by the institutional
ethics committee of the Institut Universitaire de Géria-
trie de Montréal and was conducted with the under-
standing and consent of each participant. All tests were
conducted in accordance with the Declaration of
Helsinki.
Data analysis
Basal cortisol
Basal cortisol measurements were analyzed in two differ-
ent ways: area under the curve (AUC) per day and diur-
nal cycle [44]. AUC was calculated for each of the three
basal cortisol assessment days (Days 1, 3, and 5): the
minimum number of minutes for each group between
the first and fifth (last) sample on the same day was
determined (635 min or 10 h 35 min) and taken as the
cutoff point for the AUC calculation for all three days for
all participants. New data points were interpolated based
on the curve slope at 635 min from the first sample.
On the post-DEX day (Day 2), participants took saliva
samples every hour throughout the morning only. In
order to compare cortisol values on the post-DEX day
with basal cortisol values, a new variable was computed
(AUC2) from all AUC values recalculated with a cutoff
time point of 226 min (3 h 46 min), or the minimum
number of minutes between the first and last sample on
the post-DEX day for all participants.
Diurnal cortisol values indicate the change in cortisol
level throughout the day. The diurnal cortisol measure
is the mean cortisol level at each time of day across the
three basal cortisol assessment days.
Cortisol suppression
Percent suppression after DEX administration was cal-
culated as 100 - ((AUC2 post-DEX/mean basal AUC) *
100), where AUC2 post-DEX is the area under the
curve of the post-DEX day, cut off at 226 min, and
mean basal AUC is the mean area under the curve of
the basal cortisol assessment of Day 1 and Day 5 (aver-
aged), also cut off at 226 min. Extreme outliers (> 3×
interquartile range) were determined for each group and
excluded from further analysis.
Hearing measures
The frequencies for which hearing detection thresholds
were determined were combined into three groups: Low
(250 Hz, 354 Hz, 500 Hz), Mid (707 Hz, 1000 Hz, 1414
Hz, 2000 Hz, 2828 Hz), and High (4000 Hz, 5657 Hz,
8000 Hz). Missing values were not replaced. Extreme
outliers (> 3× interquartile range) were determined
separately by ear group (control and tinnitus ears) and
excluded from further analysis.
break basal basal basal
08:00
09:00
10:00
11:00
12:00
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4
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day 1 day 2 day 3 day 4 day 5
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Figure 1 Days 1, 3, and 5: basal cortisol assessment. Saliva samples were taken 1) after waking before leaving the bed; 2) 30 min. later; 3)
immediately before lunch; 4) immediately before dinner; and 5) immediately before going to bed. DEX (dexamethasone) was administered on
Day 1 at 23:00. Day 2: samples were taken at the lab at 8:00, 9:00, 10:00, 11:00, and 12:00. Day 4: no samples were taken. Hearing assessments
(HA) were made on Day 0 (pre-DEX) and Day 2 (post-DEX) at the same time of day.
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The statistical analysis was performed with PASW Statis-
tics 18.0 and IBM SPSS 19.0. On cortisol data (AUC and
AUC2), ANOVAs were run with Group (Tinnitus vs. Con-
trol) as a between-subject factor and Day of basal cortisol
assessment (Days 1 vs. 3 vs. 5) as a within-subject factor.
On diurnal data, an ANOVA was run with Group (Tinni-
tus vs. Control) as a between-subject factor and Time of
Day (samples 1 to 5) as a within-subject variable (averaged
across Day 1 and 5). Independent sample t-tests were used
to compare sociodemographic, questionnaire, and percent
suppression variables. An analysis of covariance
(ANCOVA) on percent suppression was run to adjust for
hearing thresholds in mid and high frequencies, which
were used as covariables. Correlations were run between
TRQ scores, years of tinnitus, and percent suppression in
the Tinnitus group.
On hearing data, ANOVAs with Day (pre- vs. post-
DEX) as a within-subject factor and Ear (Tinnitus vs.
Control) as a between-subject factor were performed
separately, with the hearing threshold test (low vs. mid
vs. high frequencies) and the loudness discomfort
threshold test (1 kHz vs. 2 kH vs. 4 kHz) as within-sub-
ject variables. Non-tinnitus ears in participants with uni-
lateral tinnitus (N = 8) were excluded from this analysis.
T-tests were run for simple effects. All tests were two-
tailed and p-value was set at 0.05.
Results
Basal cortisol
On AUC data, the interaction between Group and Day
was significant, F(2, 78) = 4.11, p =. 0 2 0( s e eF i g u r e2 ) .
The Tinnitus group showed a difference in AUC across
the three days, F(2, 38) = 5.48, p = .008. A highly
significant quadratic trend was found in AUC across
days, F(1, 19) = 8.88, p = .008, with lowest mean AUC
on Day 3 of basal cortisol assessment and higher mean
AUC on Day 1 and Day 5. AUC did not differ between
days in Controls, F < 1. Neither the main effect of Day,
F(2,78) = 1.26, p = .289, nor the effect of Group, F <1 ,
was significant.
On AUC2 data, the interaction between Day and
Group just failed to reach significance, F (2, 78) = 2.51,
p = .08. However the quadratic trend was again highly
significant in the Tinnitus group, F (1, 19) = 13.02, p =
.002, but not in the Control group, F <1 ,s u g g e s t i n ga
long-lasting carryover effect of the DEX challenge in the
Tinnitus group. In order to test the possibility of an
ever more delayed dex effect, we ran an ANOVA on
each group separately with Days of basal cortisol assess-
ment (Day 1, 3, and 5) as a within-subject factor. In
Controls, pairwise comparisons (with Bonferroni correc-
tion for multiple comparisons) indicated that Days 3
and 5 did not differ significantly (p = .95), and neither
did Day 1 and Day 3 (p = .14), suggesting that by Day 3
cortisol levels had returned to normal values. In con-
trast, in Tinnitus, Days 3 and 5 differed from one
another (p = .015), and so did Days 1 and 3 (p = .03),
but not Days 1 and 5 (p = 1.00), suggesting that by Day
5 cortisol levels had returned to normal levels, but not
by Day 3. Because of this potentially confounding influ-
ence on basal cortisol levels in Tinnitus participants,
Day 3 was excluded from further analyses of basal corti-
sol measures.
Diurnal cortisol showed a normally expected circadian
pattern throughout the day (higher values in the morn-
ing, peaking at 30 min after waking up, and decreasing
gradually thereafter) in both groups, as shown by a
highly significant effect of Time of day, F (4, 160) =
70.61, p < .001, all ps < .001, for the different measure-
ment times. There was no effect of Group or any inter-
action between Time and Group, both Fs<1( s e e
Figure 3).
DEX suppression test
Suppression (% suppression) was strong in both groups,
but significantly stronger in Tinnitus participants than
Controls, with means of 95.9% and 93.8%, respectively, t
(33) = -2.19, p =. 0 3 6( s e eF i g u r e4 ) .I m p o r t a n t l y ,t h i s
suppression effect was still significant after adjusting for
detection thresholds in the Mid and High frequencies
averaged across ears, F (1, 31) = 5.84, p = .022. The %
suppression in the Tinnitus group was outside the 95%
confidence interval of the Controls (91.9%-95.6%), as
well as the more stringent 99% confidence interval
(91.7%-95.7%). In the Tinnitus group, % suppression was
not correlated with subjective tinnitus-related distress (p
= .43) or tinnitus duration in years (p = .97).
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Figure 5 shows detection and discomfort thresholds
before and after DEX challenge. On detection thresh-
olds, the interaction between Ear and Frequency was
significant F (2, 146) = 33.82, p < .001. Unsurprisingly,
Tinnitus ears had higher thresholds than Control ears in
Mid and High frequencies, t <1 ,t(76) = -5.04, p < .001,
and t(81) = -5.18, p <. 0 0 1f o rL o w ,M i d ,a n dH i g hf r e -
quencies, respectively. In both groups, hearing thresh-
olds (SD) for Mid frequencies, where sensitivity is
optimal, were lower than for Low and High frequencies,
with means of 31.5, 23.4, and 47.7 for Low, Mid and
High frequencies, respectively (all ps<. 0 0 1 ) .T h em a i n
effect of DEX was in the expected direction but not sig-
nificant, with means of 33.9 and 33.2 for pre- and post-
DEX, respectively, F (1, 73) = 2.27, p =. 1 4 .T h e r ew a s
no interaction between DEX and any other factor, all Fs
< 1. Looking at detection thresholds for frequencies 1
kHz, 2 kHz, and 4 kHz only, the same pattern of results
was found.
On discomfort thresholds, there was a trend for the
main effect of DEX towards significance, F (1, 74) =
2.94, p = .09, with more sensitive (lower) post- than
pre-DEX thresholds (means of 93.9 and 95.3, respec-
tively). Although the interaction between Ear and DEX
just failed to reach significance, F (1, 74) = 3.28, p =. 0 7
(Figure 5), the effect of DEX was driven by the lower
t h r e s h o l di nT i n n i t u se a r sp o s t - D E Xt h a np r e - D E X ,t
(33) = 2.29, p = .029 (means = 93.3 vs. 96.2, respec-
tively), whereas Control ears differed only slightly, t <1
(means = 94.0 vs. 93.8 dB, respectively). The main effect
of Frequency was significant, F (2, 164) = 14.99, p =
.001. Thresholds differed significantly, with means of
92.2, 94.3, and 96.4 for 1 kHz, 2 kHz, and 4 kHz,
respectively, all ps < .02. The DEX factor did not inter-
act significantly with any other factor, all Fs<1 .
Discussion
We report three novel findings that establish differences
between tinnitus participants and controls in terms of
cortisol hypersuppression, longer-lasting effects of the
DEX test on basal cortisol levels, and hearing discomfort
threshold. The first novel finding is that tinnitus partici-
pants had more strongly suppressed cortisol levels than
controls after pharmacological challenge, despite similar
basal cortisol levels. This is consistent with the normal
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tinnitus participants described in a previous study [23],
and supports the hypothesis that tinnitus participants
have greater sensitivity to HPA axis negative feedback.
Hypersuppression in the presence of normal or near-
normal basal cortisol levels has also been found in other
clinical populations, such as patients with chronic fati-
gue syndrome [45-47] and burnout [48]. All these find-
ings are consistent with the notion that basal cortisol
and post-DEX cortisol suppression are mediated by two
separate receptor feedback systems. More importantly,
the suppression effect was independent of hearing loss.
This is a key finding, because these factors are difficult
to disentangle in tinnitus studies [19,23], and it argues
for a true effect of tinnitus in addition to, but unrelated
to, hearing loss. Our findings therefore directly link tin-
nitus to a stress-related disorder, and not just to a hear-
ing-related disorder, as some recent population studies
suggest [12,49].
The second important finding is that tinnitus partici-
pants showed a long-lasting carryover effect of cortisol
manipulation. They had lower basal cortisol the day
after the post-DEX day assessment compared to the two
other basal cortisol assessment days, indicating not only
cortisol hypersuppression, but also a longer-lasting effect
of DEX administration. Although it cannot be excluded
that these findings could be related to slower DEX
clearance in these patients, this possibility is unlikely,
because there is no rationale for altered liver function in
this particular group, which moreover did not differ
from controls in terms of age, BMI, or physical or men-
tal health. Furthermore, the carryover effect was
observed in the tinnitus participants approximately 36
hours after DEX administration, whereas cortisol and
DEX levels should return to baseline 24 hours after oral
administration of 0.5 mg DEX [50]. A likely interpreta-
tion is that the carryover effect might have been due to
HPA axis homeostatic vulnerability, and that hypersup-
pression might have been caused by increased glucocor-
ticoid sensitivity.
The third original finding is an association between
cortisol suppression and cortisol-induced hearing dis-
comfort in humans. When cortisol levels were sup-
pressed, sound loudness tolerance decreased. Because
the dB scale is logarithmic, a 3 dB reduction in level
corresponds to a 50% decrease in sound pressure. At
high sound levels, sound level tolerance therefore
decreases markedly. This effect was more pronounced
in tinnitus ears, which appeared to be more sensitive to
cortisol manipulation, supporting a direct effect of glu-
cocorticoid action on the inner ear cells in addition to
the well-known systemic anti-inflammatory or immuno-
suppressive effect, as suggested in previous studies
[35,51,52]. A much smaller (statistically non-significant)
dB change was observed for the sound detection thresh-
old, but the effect of cortisol manipulation was in a con-
cordant direction (i.e., lower threshold after cortisol
suppression). One likely explanation is that at such low
sound levels the sensory organs operate at maximal sen-
sitivity, possibly resulting in a floor effect, given the
highly sensitive adaptive procedure used in this study.
The changes found in the discomfort threshold are con-
sistent with previous human studies showing that
restored cortisol levels in individuals with cortisol deple-
tion increased hearing threshold and discomfort level
[36]. They are also consistent with a recent study
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Page 7 of 10showing that discomfort threshold and emotional
exhaustion are strong predictors of both tinnitus pre-
sence and prevalence [12]. Future studies could corrobo-
rate and extend these findings by examining dose-
response relationships between cortisol manipulations
and changes in hearing thresholds using auditory brain-
stem responses, for instance.
A strength of our study is that the same participants
were tested for both basal cortisol and responsiveness to
pharmacological challenge, which allowed examining
both receptor types and consolidating previous findings.
Because all participants were also rigorously screened
for health status, greater HPA axis disturbance could be
found in participants with more comorbid conditions. In
addition, the very small variation in post-DEX cortisol
levels in tinnitus participants could indicate a ceiling
effect. An even lower dose of DEX (i.e., 0.25 mg) could
be used to investigate whether tinnitus participants dis-
play even greater suppression [53]. Although these dif-
ferences in cortisol suppression document for the first
time HPA axis disturbance at the pituitary level in tinni-
tus, a limitation of our study is that no information is
provided on how negative feedback inhibition occurs in
the tinnitus brain. Practical reasons prevented us from
performing blood and cerebrospinal fluid punctures, so
adrenocorticotropic hormone (ACTH, secreted by the
anterior pituitary) and corticotropin-releasing factor
(CRF, released from the parvocellular neurons of the
parventricular nucleus of the hypothalamus) levels were
n o ta s s e s s e d .C R Fi st h em o s td o m i n a n tt r i g g e ro ft h e
H P Aa x i sr e s p o n s e .C R Fa l s os e r v e sa sat r a n s m i t t e rt o
modulate anxiety-related behaviour, cognitive function,
and sleep, and it projects to the limbic nuclei and the
brainstem. Therefore, further pharmacological chal-
lenges using combined DEX/CRF tests should be under-
taken to more precisely identify the locus of the
dysregulation. In the absence of any relevant data, and
given the rarity of these anomalies in clinical popula-
tions, our working hypothesis is that tinnitus patients
have anomalies in the negative feedback sensitivity sys-
tem. This is a valuable finding in itself, especially given
the deleterious consequences of HPA axis disturbance
on health (e.g., on the immune system, pain, and fati-
gue). However, whether these alterations are a conse-
quence of suffering from this chronic phantom sound in
the ears, or instead a predisposition for the disorder, is
unknown. Due to the cross-sectional design, the rela-
tionship between HPA axis disturbance and tinnitus is
an association, not a causality, and we cannot conclude
whether stress precedes, maintains, or is a consequence
of tinnitus. Intuitively, we may posit a causal relation-
ship (i.e., that tinnitus produces the abnormal stress
response). However, in a recent tinnitus model,
Rauschecker and colleagues [54] suggested that a limbic
system dysfunction would actually trigger tinnitus by
blocking its inhibitory input to the thalamus. That is, a
tinnitus signal would originate from the lesion-induced
plasticity of the auditory pathways (i.e., some degree of
peripheral damage is assumed to be always present,
even when not measurable in the audiogram [55]). Nor-
mally, this signal would be tuned out by feedback con-
nections from limbic regions, which would prevent
tinnitus from reaching the auditory cortex. In the pre-
sence of limbic damage, this “noise-cancellation” would
collapse and chronic tinnitus would result. This could
explain why some individuals with hearing loss do not
experience tinnitus. Our results would therefore show
that stress is a predisposing factor for tinnitus, and not
just a consequence. Stress has also been suggested as a
predisposing factor for CFS [56]. Future studies should
examine this possibility by following up large cohorts
with and without hearing loss over time to determine
which individuals develop tinnitus in relation to various
stress-related factors.
In any case, considering tinnitus as a stress-related
disorder by demonstrating HPA axis disturbance can
open up new research avenues. For instance, studies of
similar disorders show the same anomalies. There is a
great need for new pharmacological targets in tinnitus
[57], and a deeper understanding of HPA disturbance
could lead to the development of pharmacotherapy tar-
geting the HPA axis [58] as well as monitoring tools to
assess the efficacy of tinnitus treatments and therapies.
Conclusions
Our findings suggest heightened glucocorticoid sensitiv-
ity in tinnitus in terms of an abnormally strong GR-
mediated HPA-axis feedback (despite a normal MR-
mediated tone) and lower tolerance for sound loudness
with suppressed cortisol levels. Long-term stress expo-
sure and its deleterious effects therefore constitute an
important predisposing factor for, or a significant patho-
logical consequence of, this debilitating hearing disorder.
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